Stock DNA
Pharmaceuticals & Biotechnology
CAD 22 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.29
-375.97%
3.53
Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Jun 2025)
Net Profit:
-5 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-64.71%
0%
-64.71%
6 Months
-66.67%
0%
-66.67%
1 Year
-60.0%
0%
-60.0%
2 Years
-90.06%
0%
-90.06%
3 Years
-90.27%
0%
-90.27%
4 Years
-94.75%
0%
-94.75%
5 Years
-12.2%
0%
-12.2%
Perimeter Medical Imaging AI, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
26.03%
EBIT Growth (5y)
-256.66%
EBIT to Interest (avg)
-15.09
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.37
Sales to Capital Employed (avg)
0.08
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.53
EV to EBIT
-0.83
EV to EBITDA
-0.87
EV to Capital Employed
4.58
EV to Sales
9.10
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-550.14%
ROE (Latest)
-375.97%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
0.70
0.80
-12.50%
Operating Profit (PBDIT) excl Other Income
-5.10
-5.90
13.56%
Interest
0.00
0.00
Exceptional Items
0.10
0.00
Consolidate Net Profit
-5.40
-6.20
12.90%
Operating Profit Margin (Excl OI)
-7,722.80%
-7,884.90%
16.21%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is -12.50% vs 100.00% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is 12.90% vs -29.17% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1.20
0.50
140.00%
Operating Profit (PBDIT) excl Other Income
-24.80
-21.40
-15.89%
Interest
0.00
0.20
-100.00%
Exceptional Items
4.50
3.60
25.00%
Consolidate Net Profit
-18.30
-18.90
3.17%
Operating Profit Margin (Excl OI)
-22,276.80%
-40,892.20%
1,861.54%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 140.00% vs 150.00% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 3.17% vs -46.51% in Dec 2023
About Perimeter Medical Imaging AI, Inc. 
Perimeter Medical Imaging AI, Inc.
Pharmaceuticals & Biotechnology
Perimeter Medical Imaging AI, Inc. is a Canada-based medical device company. The Company develops and commercializes in-procedural medical imaging tools. Its tools enable surgeons, radiologists and pathologists to visualize microscopic tissue structures during a clinical procedure. The Company’s OTIS platform is a point-of-care imaging system that provides clinicians with real-time, sub-surface image volumes of the margin of an excised tissue specimen. OTIS is based on optical coherence tomography (OCT), a technology with commercial applications in ophthalmology and vascular imaging. OTIS scans the specimen in the consumable container during the surgical procedure, with results available for display on the device screen and over the picture archiving and communications systems (PACS), enabling collaboration between surgeon, radiologist and pathologist. The Company is also engaged in developing artificial intelligence and machine learning-enabled image assessment tools.






